We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acute Haemodynamic Impact of an IV Glucose-Injection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00426114
Recruitment Status : Withdrawn
First Posted : January 24, 2007
Last Update Posted : April 10, 2009
Sponsor:
Information provided by:
University Hospital, Ghent

Brief Summary:
Patients with peritoneal dialysis will be administered an IV glucose-injection to evaluate the haemodynamic impact of this injection. The patients will be matched with healthy volunteers.

Condition or disease Intervention/treatment Phase
Peritoneal Dialysis Drug: Administration of an IV glucose-injection Phase 2

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Acute Haemodynamic Impact of an IV Glucose-Injection

Resource links provided by the National Library of Medicine

Drug Information available for: Dextrose
U.S. FDA Resources




Primary Outcome Measures :
  1. Haemodynamic parameters
  2. Glycemia


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • > 18 years old
  • Stable clinical condition
  • Either peritoneal dialysis (at least one month) either matched healthy subject

Exclusion Criteria:

  • Heart Failure
  • Diabetes requiring insulin treatment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00426114


Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Wim Van Biesen, MD, PhD University Hospital, Ghent

Additional Information:
Responsible Party: Wim Van Biesen, University Hospital Ghent
ClinicalTrials.gov Identifier: NCT00426114     History of Changes
Other Study ID Numbers: 2007/016
First Posted: January 24, 2007    Key Record Dates
Last Update Posted: April 10, 2009
Last Verified: April 2009